Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
Pathos AI Raises $365M in Series D Financing to Advance AI Oncology Drug Development
The firm is developing an artificial intelligence engine that aims to accelerate the development and validation of biomarker-driven precision medicine drugs.
Gene Solutions, NEWCL Establish NGS Lab in Taiwan
The companies aim to jointly commercialize Gene Solutions' suite of prenatal and cancer tests throughout Taiwan.
MiRxes Launches HK$880.5M IPO on Hong Kong Stock Exchange
The Singaporean company said it will use the proceeds to support commercialization of its gastric cancer test, further assay development, and other business purposes.
MDxHealth Q1 Revenues Leap 22 Percent
The company's tissue-based test volume grew 41 percent while liquid-based test volume rose 9 percent.
Lucid Diagnostics Q1 Revenues Fall 17 Percent
EsoGuard esophageal precancer testing volume rose 25 percent to 3,034 tests in the first quarter compared to 2,420 tests in Q1 2024.
May 8, 2025
May 5, 2025